Kazia Therapeutics (KZIA) Other Non-Current Liabilities (2017 - 2024)

Kazia Therapeutics' Other Non-Current Liabilities history spans 5 years, with the latest figure at $2.5 million for Q2 2024.

  • For Q2 2024, Other Non-Current Liabilities fell 39.56% year-over-year to $2.5 million; the TTM value through Jun 2024 reached $2.5 million, down 39.56%, while the annual FY2024 figure was $2.5 million, 39.56% down from the prior year.
  • Other Non-Current Liabilities reached $2.5 million in Q2 2024 per KZIA's latest filing, down from $4.1 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $5.9 million in Q2 2022 to a low of $2.5 million in Q2 2024.
  • Average Other Non-Current Liabilities over 3 years is $4.1 million, with a median of $4.1 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Liabilities: crashed 30.42% in 2023, then tumbled 39.56% in 2024.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $5.9 million in 2022, then plummeted by 30.42% to $4.1 million in 2023, then crashed by 39.56% to $2.5 million in 2024.
  • Per Business Quant, the three most recent readings for KZIA's Other Non-Current Liabilities are $2.5 million (Q2 2024), $4.1 million (Q2 2023), and $5.9 million (Q2 2022).